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In this special issue of Journal of Lipids, we acknowledge the
contributions by several experts oﬀering timely perspectives
on the complex interactions between bile acids and nuclear
receptors (NRs) on lipid metabolism and liver diseases at
diﬀerent levels and contexts in the body.
NRs are found within the interior of cells and are defined
as ligand-activated transcriptional regulators of several key
aspects of body physiology and pathophysiology. NRs regulate gene transcription through interaction with cellular
coactivators and corepressors. In the liver, NRs play a key role
in a large variety of metabolic processes such as cholesterol,
bile acid, fatty acid, and glucose homeostasis, as well as drug
disposition. Also, additional critical processes involving the
pathophysiology of liver diseases—inflammation and fibrosis, regeneration, cell diﬀerentiation, and tumor formation—
are modulated by NRs. Of note, NRs are or might soon become drug targets. Despite the huge accumulation of knowledge in the field, the true comprehension of interactions
between bile acids and NRs on lipid metabolism and hepatobiliary diseases has remained elusive. Thus continuous eﬀorts
are being made to understand the molecular functions of
NRs, the significance of bile acid-controlled signaling pathways, and interactions of NRs on a number of metabolic and
hepatic diseases.
The paper of T. Li and Y. L. Chiang is focused on the role
of bile acid signaling in the regulation of glucose and

lipid metabolism. Besides their detergent properties and key
physiological functions, bile acids are also acting as potent
metabolic regulators of glucose and lipid homeostasis. The
identification of bile acid-activated nuclear receptor farnesoid X receptor (FXR) and cell surface G-protein-coupled
receptor TGR5 has significantly advanced our understanding
on how bile acid signaling regulates cellular metabolism in
health and disease. Thus, novel therapeutic strategies can be
envisioned which target bile acid metabolism for the treatment of metabolic disorders such as obesity, insulin resistance, and the metabolic syndrome.
NRs comprise one of the most abundant classes of transcriptional regulators of metabolic diseases and have
emerged as promising pharmaceutical targets. The paper by
G. Garruti et al. deals with the myriad roles of small heterodimer partner (SHP), a unique orphan nuclear receptor
lacking a DNA-binding domain, but containing a putative
ligand-binding domain. About half of mammalian NRs and
several transcriptional coregulators can interact with SHP.
SHP is a transcriptional regulator aﬀecting multiple key biological functions and metabolic processes including cholesterol, bile acid, and fatty acid metabolism, as well as reproductive biology and glucose-energy homeostasis. In humans,
studies are emerging on the association of SHP genetic
variation with birth weight, high body mass index, obesity,
insulin resistance, and diabetes. Future research must be
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focused on synthetic ligands acting on SHP as a potential
therapeutic target in a series of metabolic abnormalities.
One important issue in lipidology is the understanding
of the molecular mechanisms whereby cholesterol and fatty
acids are absorbed from the intestine and are transported
to the liver. The cholesterol absorption inhibitor ezetimibe
can significantly reduce plasma total and LDL cholesterol
concentrations by inhibiting the Niemann-Pick C1-like 1
protein (NPC1L1), an intestinal sterol influx transporter that
can actively facilitate the uptake of cholesterol for intestinal
absorption. The paper by O. de Bari et al. emphasizes the
novel concept that, ezetimibe treatment also induces a complete resistance to two frequent metabolic abnormalities,
namely, cholesterol gallstones and nonalcoholic fatty liver
disease (NAFLD). Furthermore, it prevented hypercholesterolemia in mice on a Western diet. This model has high
translational value and points to a key role for chylomicrons,
the natural lipid carriers used by enterocytes to transport
cholesterol and fatty acids into the body. The hypothesis that
ezetimibe could prevent two prevalent hepatobiliary diseases
(i.e., cholesterol cholelithiasis and liver steatosis) possibly
through the regulation of chylomicron-derived cholesterol
and fatty acid metabolism in the liver is discussed here.
Because several proteins are implicated in determining
biliary lipid secretion in the liver and are regulated by several
transcription factors, including nuclear receptors liver X
receptor (LXR) and FXR, the paper by M. C. Vázquez et al.
is focused on molecular mechanisms underlying the link
between nuclear receptor function and the formation of
cholesterol gallstones. A potent role for estrogen receptors
in the pathogenesis of cholesterol gallstone disease, involving
both genomic and nongenomic activation of signaling pathways, is discussed. Evidence in this respect is heavily supported by human and murine genetic, physiological, pathophysiological, and pharmacological studies. Indeed, expanding the
knowledge about the role of NRs in gallstone formation will
certainly lead to the discovery of novel and more eﬀective
therapeutic strategies in a typical example of a metabolic
“mass disease,” that is, cholesterol cholelithiasis.
In the wide field of lipopathy, NAFLD is currently evolving as the most common liver disease worldwide, with potential costly and severe sequelae, including liver cirrhosis
and hepatocellular carcinoma. In his paper, M. Fuchs underscored the concept that NAFLD not only represents an insulin resistance state characterized by a cluster of dysmetabolic
cardiovascular risk factors, but also represents an independent risk factor for cardiovascular diseases. Of note, the bile
acid-activated nuclear receptor FXR has been shown to play
a role not only in bile acid but also in lipid (cholesterol and
triglyceride) metabolism and glucose homeostasis. Specific
targeting of FXR may be an elegant and very eﬀective way to
readjust dysregulated nuclear receptor-mediated metabolic
pathways. Activation of FXR may result in not only beneficial
actions but also potential undesirable side eﬀects. One
example is the (still unpredictable) balance between pro- and
anti-atherogenic eﬀects of FXR activation.
J. A. López-Velázquez et al. described the important role
of several NRs in the liver as regulators of several critical
metabolic steps involved in the pathogenesis of NAFLD. Such
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crucial steps include fat storage, export, uptake, oxidation,
and lipolysis. A whole family of NRs is targeted by many
ligands controlling lipid metabolism including fatty acids,
oxysterols, and lipophilic molecules. Understanding the
molecular mechanisms underlying the involvement of NRs
in the pathogenesis of NAFLD may, therefore, oﬀer targets
for the development of new treatments of one of the most
frequent chronic liver diseases worldwide.
In their paper, R. Müllenbach et al. provided an update
on genetic variants of NRs involved in regulating important
aspects of liver metabolism. One such aspect is the application of NRs in genetic diagnosis of monogenic (Mendelian)
liver diseases and their uses in clinical diagnosis. Moreover,
a role of NR polymorphisms in common diseases can be
anticipated, linking regulatory networks to complex and variable phenotypes. Technical advances contribute to the restless expansion of knowledge and include transgenic animal
models, expression quantitative trait loci (eQTL) mapping,
and genomewide association studies (GWASs). Thus, it is
highly likely that personal genome information might eventually be able to predict a variety of risks associated with an
individual’s lifestyle such as high fat diet and alcohol as well
as susceptibility to infectious liver diseases such as hepatitis
B or C.
Menopause is a consequence of the normal aging process
in women and it is thought that menopause is associated with
a higher risk for cardiovascular diseases. Indeed, the postmenopause lipid profile is often altered, which represents
a risk factor for cardiovascular diseases. The paper by P. J.
Oliveira et al. reports on the mechanisms linking alterations
of mitochondrial bioenergetics in the heart, as a consequence
from normal aging and/or from the menopausal process,
to decreased fatty acid oxidation and accumulation of fatty
acid intermediates in the cardiomyocyte cytosol. Such lipotoxic consequences might represent the important link to
increased cardiovascular risk in the menopausal women.
In conclusion, the field of lipidology has become even
more complex and exciting when considering that the discovery of NRs and their pleiotropic functions have opened
the way to multidimensional, multidisciplinary and translational studies. Since NRs are involved in virtually all physiological functions, understanding how NRs work is therefore
essential to explain the complex pathophysiological mechanisms underlying liver and extrahepatic diseases. A new era
in which NRs will represent valid therapeutic targets for
several disorders is hopefully approaching.
Lastly, we hope that this contribution will also help both
young and experienced investigators in their daily diﬃcult
task to expand their research in the field of experimental and
clinical lipidology in health and disease.
David Q.-H. Wang
Brent A. Neuschwander-Tetri
Piero Portincasa
William M. Pandak
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